Shiga toxin (Stx)-1 and Stx-2 are involved in the pathogenesis of hemolytic uremic syndrome (HUS) and severe systemic complications following enterohemorrhagic Escherichia coli (EHEC) infection in humans. [1] [2] [3] [4] Stxs have an AB 5 structure, in which a single catalytic A subunit is associated with five identical B subunits. The B pentamer is responsible for the toxin binding to eukaryotic cell-surface glycolipid receptors such as galabiosyl (Gb 2 )-ceramide and globotriaosyl (Gb 3 )-ceramide. The susceptibility of target cells to Stxs is dependent on the presence of the functional glycolipid receptors. 5, 6) After binding, Stxs are internalized into the cells, and then the A subunit exerts RNA N-glycosidase activity, resulting in inhibition of protein synthesis by catalytic inactivation of 28S rRNA. 7, 8) Thus, the binding of Stxs to the receptor is the primary event causing Stx-mediated diseases.
The clustering of Gb 3 molecules is important for strong binding to Stxs. 12) In light of these findings, many synthetic compounds mimicking the natural receptors have been investigated for eliminating Stxs from the intestine and/or neutralizing Stxs in the circulation, as a therapeutic strategy for protecting patients from serious Stx-mediated diseases. 9, 10, [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] All of these previously reported compounds possess repeated Gb 3 mimic structures in a molecule with various backbones on expecting clustering effect of the saccharide moiety, although there was one exception of adamantyl-Gb 3 , 10) a Gb 3 monovalent derivative, that was speculated to assemble into small aggregates for activity.
In the present study, we synthesized novel Gb 3 -and Gb 2 -conjugated derivatives with a phosphatidyl residue, a sugar unit monomer in the chemical structure, which would be expected to form liposomes and clusters of the sugar unit to neutralize Stx-1 and Stx-2. These compounds showed strong neutralizing activity against not only Stx-1 but also Stx-2. In the present paper, we propose monovalent Gb 3 -/Gb 2 -derivatives conjugated with phosphatidyl residue as a new type of Stx-neutralizing agent.
MATERIALS AND METHODS

Compounds
The structures of the compounds used in this study are shown in Fig. 1 . Gb 3 and Gb 2 conjugated with phosphatidylethanolamine dipalmitoyl (PEDP) residue are referred to as Gb 3 -PEDP and Gb 2 -PEDP, respectively. Gb 3 conjugated with dipalmitoyl phosphatidyl hexyl (DPPA) residue is referred to as Gb 3 -DPPA. These compounds were dissolved in dimethyl sulfoxide at a concentration of 2 mM, then diluted 10 times in phosphate-buffered saline (PBS, pH 7.4) and stored at 4°C. The stock solutions were diluted with culture medium just before use, and sonicated for 10 min in a water bath sonicator (UT-105, Sharp, Manufacturing Systems, Osaka, Japan). Gb 3 and Gb 2 conjugated with acrylamide copolymers and fluorescein are referred to as Gb 3 -copolymer (sugar unit to acrylamide molar ratioϭ1 : 6.2), Gb 2 -copolymer (sugar unit to acrylamide molar ratioϭ 1 : 4.9), Gb 3 -fluorescein and Gb 2 -fluorescein, respectively. These reference compounds were dissolved in water at an appropriate concentration and stored at 4°C. The stock solutions were diluted with culture medium just before use. The concentration of Gb 3 -/Gb 2 -copolymer was defined as the sugar unit molarity in the solution.
Toxin Preparation Stx-1 and Stx-2 were prepared as previously described, from Escherichia coli BL21/pETSTX1 and E. coli GPU993, respectively. 9, 23) Briefly, E. coli BL21/ pETSTX1 for preparing Stx-1 were grown at 37°C with shaking in Luria-Bertani (LB) broth supplemented with 60 mg/l ampicillin (Wako, Pure Chemicals Industries, Osaka, Japan). At the mid-logarithmic phase growth, isopropyl b-D(Ϫ)-thiogalactopyranoside (Wako, Pure Chemicals Industries) was added at a final concentration of 1 mM, and the culture was continued for an additional 6 h. The cell pellet was harvested by centrifugation, sonicated (Insonator 201M, Kubota, Tokyo, Japan) and the supernatant of the sonicate was passed through 0.22 mm filter (Millex; Millipore, Bedford, MA, U.S.A.) and used for further purification of Stx-1.
E. coli GPU993, an stx1 deletion mutant of E. coli GPU96MM (clinical isolate serotype O157:H7, producing Stx-1 and Stx-2) were cultured in Syncase broth for preparing Stx-2. At the mid-logarithmic phase growth, 0.6 mg/ml mitomycin C (Kyowa Hakko Kogyo, Tokyo, Japan) was added to the culture to enhance Stx-2 production. After 6 h incubation with mitomycin C, the culture supernatant was concentrated by ultrafiltration using a 30000 molecular weight cut-off membrane (Pellicon 2 Cassette filter Biomax 30, Millipore) and used for further purification of Stx-2.
Stx-1 and Stx-2 were highly purified as previously described 9) by affinity chromatography using Gb 3 ceramide (Nacalai Tesque, Kyoto, Japan) immobilized on octyl Sepharose CL-4B (Amersham Pharmacia Biotech, Uppsala, Sweden). The cytotoxic activity of the Stx-1 and Stx-2 preparations was determined as units of 50% cytotoxic dose (CD 50 ) by concentration-response curve in the cytotoxic assay as described below. The concentrations of 1.78 pg/ 200 ml/well Stx-1 and 0.24 pg/200 ml/well Stx-2 corresponded to one CD 50 , respectively.
Neutralization Assay Cytotoxicity assays using HeLa 229 cells were performed to evaluate the neutralizing activity of compounds against Stx-1 and Stx-2. The cells were maintained in Dulbecco's modified Eagles medium (DMEM) (Nissui Pharmaceutical, Tokyo, Japan) supplemented with 10% heat-inactivated fetal calf serum (ICN Biomedicals, Aurora, OH, U.S.A.), 100 U/ml penicillin G and 0.1 mg/ml streptomycin at 37°C in an atmosphere with 5% CO 2 . The cells were seeded at 5ϫ10 3 cells per well in 96-well flat bottom plates (Nunclon; Nalge Nunc International, Copenhagen, Denmark) and incubated for 24 h. The growth medium was replaced with 100 ml fresh medium, and 100 ml Stx-1 or Stx-2 were added. After 48 h incubation, the wells were washed and then incubated for 2 h with 10% AlamarBlue (Trek Diagnostic Systems, West Sussex, U.K.) diluted in Hanks' medium (Nissui Pharmaceutical). Fluorescence intensity (FI) of the wells was measured at 530 nm excitation and 590 nm emission (CytoFluor 2350, Millipore) to calculate the number of viable cells. The experiments were performed in triplicate sets. The percentage of viable cells was calculated as follows: % viable cellsϭ(Stx FIϪbackground FI)/(PBS FIϪbackground FI)ϫ100.
Neutralizing activity of compound was evaluated against Stxs of a 5 CD 50 units/200 ml/well final concentration. Until otherwise indicated, an equal volume mixtures of Stx-1 or Stx-2 (100 CD 50 units/ml) with the tested compound at various concentrations were incubated at 37°C for 1 h with tightly capped microtubes, and then subjected to the cytotoxicity assay. If necessary, percent inhibition of Stx cytotoxicity by the compounds was calculated as follows: % inhibitionϭ (compound FIϪStx FI)/(PBS FIϪStx FI)ϫ100, and the IC 50 was estimated using GraphPad PRISM (GraphPad Software, San Diego, CA, U.S.A.).
Statistics The results are expressed as meansϮS.E.M. Statistical analyses were performed using GraphPad PRISM (GraphPad Software). Significant differences between groups were evaluated using Dunnett's multiple comparison test after one-way analysis of variance (ANOVA).
RESULTS
Neutralizing Activity of Monovalent Gb 3 -and Gb 2 -Derivatives against Stx-1 and Stx-2 Neutralizing activities of monovalent derivatives were compared for Gb 3 -PEDP, Gb 2 -PEDP, Gb 3 -DPPA, Gb 3 -fluorescein and Gb 2 -fluorescein at a final concentration of 1 mM (Fig. 2) .
Gb 3 -PEDP and Gb 2 -PEDP neutralized Stx-1 and Stx-2 with a statistical significance from the control at pϽ0.001. Gb 3 -DPPA showed a tendency to neutralize Stx-1 without any statistical significant difference from the control, and did not show any neutralizing activity against Stx-2. Monovalent derivatives of Gb 3 -fluorescein and Gb 2 -fluorescein used for comparison did not show any neutralizing activities.
Comparison of Neutralizing Activity The neutralizing activities of Gb 3 -PEDP, Gb 2 -PEDP, Gb 3 -DPPA, Gb 3 -copolymer and Gb 2 -copolymer were compared (Fig. 3) . Gb 3 -PEDP neutralized Stx-1 at a concentration (IC 50 ϭ0.5 nM) comparable with that of Gb 3 -copolymer (IC 50 ϭ0.58 nM) (Fig. 3 upper  left) , and neutralized Stx-2 at a concentration more than (Fig. 3 lower left) . Gb 2 -PEDP neutralized Stx-1 at a concentration 42 times lower (IC 50 ϭ 12.54 nM) than that of Gb 2 -copolymer (IC 50 ϭ527.3 nM) ( Fig.  3 upper right) , and neutralized Stx-2 at a concentration 4000 times lower than that of Gb 2 -copolymer (IC 50 Ͼ50ϫ10 3 nM) ( Fig. 3 lower right) . In addition, Gb 3 -PEDP showed activity against both Stx-1 and Stx-2 at lower concentrations than Gb 2 -PEDP. Although the data are not shown here, Gb 3 -DPPA inhibited Stx-1 by only 47% and Stx-2 by 25% at the available highest concentration (10ϫ10 3 nM), and the IC 50 value of Gb 3 -DPPA was not calculable for either Stx-1 or Stx-2.
Neutralizing Activity of Gb 3 -PEDP against Stxs after the Toxin-Binding to Target Cells Gb 3 -PEDP was examined to determine whether it could neutralize Stxs after the toxin had bound to the target cells. In this experiment, Gb 3 -PEDP was added to the cells after washing Stx-1 and/or Stx-2 out. The concentration of Stx-1 and Stx-2 added to the cells was 5 CD 50 units/200 ml/well and was determined as the minimum concentration to decrease viable cells with a statistical significance from the untreated cells (Table 1) . The pulsed Stx-1 and Stx-2 decreased viable cells to 75.7Ϯ2.0% and 70.7Ϯ4.2%, respectively, and Gb 3 -PEDP did not affect the decreases (Fig. 4) .
Effect of Pre-incubation with Gb 3 -PEDP on Stx Cytotoxicity Gb 3 -PEDP was added to the target cells, and then Stx-1 or Stx-2 was added after washing out Gb 3 -PEDP. In this case, Gb 3 -PEDP did not affect the cytotoxicity of Stx-1 and Stx-2 even at the highest dose of 50 nM (Fig. 5 upper  panel) , whereas Gb 3 -PEDP neutralized Stx-1 and Stx-2 without washing out (Fig. 5 lower panel) .
DISCUSSION
Recently, there has been an increasing interest to find specific therapeutic options to treat Stx-mediated diseases. Epidemiologic data suggest that Stx-2-producing EHEC O157:H7 strains are more frequently associated with HUS than strains producing only Stx-1. 24, 25) Thus, it is important to develop novel compounds that show neutralizing activity against not only Stx-1 but also Stx-2, as an effective therapeutic strategy. The equal volume mixtures of Stxs (100 CD 50 units/ml) with the compounds were incubated for 1 h at 37°C, and then subjected to the cytotoxicity assay. The final concentration of Stxs was 5 CD 50 units/200 ml/well. Each point represents the mean of triplicate sets. IC 50 of the compounds was analyzed from dose-response curves using GraphPad Prism software. 18.2Ϯ3.53*** 11.3Ϯ0.10*** 100 13.6Ϯ0.61*** 10.5Ϯ0.38*** Stx-1 or Stx-2 was added to the cells at various concentrations under ice-cooling. The cells were kept on ice for 30 min, and then washed by replacing the cooled medium 5 times to remove free/unbound Stxs. The pulsed cells with Stx-1 or Stx-2 were incubated for a further 48 h for the cytotoxicity assay. N: cells not treated with Stx. *, *** Statistically significant difference from N at pϽ0.05 and pϽ0.001, respectively (Dunnet's test).
We previously reported that Gb 3 -/Gb 2 -copolymer showed neutralizing activity against 1 CD 50 of Stx-1 and Stx-2. 9) In this study, the neutralizing activities of the compounds were examined to 5 CD 50 of Stx-1 and Stx-2 in comparison with Gb 3 -/Gb 2 -copolymers by concentration-inhibition curves and IC 50 values. Gb 3 -PEDP showed the 50% inhibition against Stx-1 at 0.5 nM and Stx-2 at 2.26 nM (Fig. 3) and the activities were stronger than those of Gb 2 -PEDP. Gb 3 -copolymer showed the inhibition against Stx-1 at 0.58 nM but required more than 50 mM for Stx-2. These results indicate that Gb 3 -PEDP has a strong potency to neutralize not only Stx-1 but also Stx-2. Gb 3 -PEDP did not affect the cytotoxicity of Stxs after the toxin-binding to the target cells (Fig. 4) . In addition, Gb 3 -PEDP showed the neutralizing activity only by co-existing with Stxs and the susceptibility of the target cells to the toxins was not affected by the pre-incubation with Gb 3 -PEDP (Fig. 5) . These results suggest that Gb 3 -PEDP neutralized Stx-1 and Stx-2 by inhibiting the binding to the target cells.
As discussed earlier, strong binding of Stxs to the glycolipid receptors is mainly attributed to the multiple interaction of the B pentamer of the toxins to the saccharide moiety of the receptors. 26, 27) Moreover, the clustering of Gb 3 in lipid rafts on the cell membrane has been shown to play an important role in the binding of Stxs. 11, 12) We 9) and others 21) reported on the importance of Gb 3 density per molecule for the neutralization of Stxs, especially Stx-2, using Gb 3 -copolymers with different molar ratios of sugar unit to acrylamide. Here, Gb 3 -PEDP and Gb 2 -PEDP neutralized not only Stx-1 but also Stx-2, although these compounds have a monomeric chemical structure, while both Gb 3 -fluorescein and Gb 2 -fluorescein, which are also monomer did not neutralize Stx activity, even at the higher concentration of 1 mM. The inactivity of Gb 3 -fluorescein and Gb 2 -fluorescein was in accordance with our previous report, 9) which also demonstrated that the monomer Gb 3 -dansyl does not show Stx-neutralizing activity. As a mechanism for Gb 3 -PEDP and Gb 2 -PEDP to have a neutralizing activity on Stx-1 and Stx-2, it is likely that the compounds formed liposomes and made flexible clusters of sugar units to give a conformation suitable for binding to the B subunit pentamers of Stx-1 and Stx-2. It is known that Stx-1 and Stx-2 differ in their binding profile and affinity for the glycolipid receptor Gb 3 -ceramide.
28) The strong neutralizing activity of Gb 3 -/Gb 2 -PEDP not only to Stx-1 but also to Stx-2, may be dependent on the flexibility of the liposomes. However, this needs to be further studied in detail.
Gb 3 -DPPA showed only a weak neutralizing activity against Stx-1. Gb 3 -DPPA has a structure similar to that of Gb 3 -PEDP, but lacks nitrogen in the spacer between the sugar and phosphatidyl residue. In this study, the tested compounds were simply diluted in the culture medium without any special procedure to make liposomes. We speculate that it is difficult for Gb 3 -DPPA to form liposome naturally by the lack of nitrogen in the spacer for the reason not to show strong neutralizing activity. There is, however, a possibility for Gb 3 -DPPA to form liposome if subjected to the specific procedure, although we are yet to examine this. The sugar unit density and fluidity of not only Gb 3 -/Gb 2 -PEDP but also Gb 3 -DPPA liposomes can be expected to be controlled by mixing with other phospholipids and/or cholesterol as a tool to investigate the optimal condition for neutralizing Stx-1 and Stx-2 with higher affinity for the toxins.
Although it remains to be clarified the precise mechanism for the compounds to show the neutralizing activity against Stxs and to be assessed the in vivo protective activity of these compounds, we propose here monovalent Gb 3 -/Gb 2 -derivatives conjugated with phosphatidyl residue as a novel class of Stx-neutralizing agent. Upper panels: Gb 3 -PEDP was added to the target cells in advance. After 2 h incubation with Gb 3 -PEDP at 37°C, Gb 3 -PEDP was washed out by replacing the fresh medium 5 times. Stx-1 or Stx-2 was then added to the cells at a final concentration of 5 CD 50 units/200 ml/well for the cytotoxicity assay. Lower panels: Stx-1 or Stx-2 was added to the wells without washing out Gb 3 -PEDP. C: Control. Each column represents the meanϮS.E.M. of triplicate sets. *** Statistically significant difference from the control at pϽ0.001 (Dunnet's test). 
